September 4 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Tuesday that its CEO - Ognyan Donev, has acquired 954 shares in the company at a price of 3.2789 levs ($1.842/1.676 euro) apiece.